Aspect Medical Applies EEG Tech To Clinical Depression, Drug Research
This article was originally published in The Gray Sheet
Executive Summary
The neuroscience division of Aspect Medical Systems expects late 2004 results of a Massachusetts General Hospital (MGH) trial studying the firm's quantitative EEG-based technology as a correlate of depression treatment outcomes will help support a clinical management indication
You may also be interested in...
Aspect Enters ICU With BIS Anesthesia Monitor Technology: $675 Mil. Market
Aspect Medical Systems intends to expand into the $300-$350 mil. market for emergency room and interventional radiology applications with the BIS XP Bispectral Index anesthesia monitoring technology platform within nine to 15 months, the firm says
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.